[Streptomycin concentration characteristics in healthy eye tissues and those affected with experimental tuberculosis].
D000681:Amylases / Q000008:administration & dosage; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations / Q000008:administration & dosage; D004357:Drug Synergism; D005123:Eye / Q000378:metabolism*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D008297:Male; D010447:Peptide Hydrolases / Q000008:administration & dosage; D011817:Rabbits; D013307:Streptomycin / Q000378:metabolism*; D013997:Time Factors; D014018:Tissue Distribution; D014392:Tuberculosis, Ocular / Q000378:metabolism*
D004338:Drug Combinations; D005343:Fibrinolytic Agents; C009402:amylase, phosphates, proteases drug combinations; D000681:Amylases; D010447:Peptide Hydrolases; D013307:Streptomycin
Osobennosti kontsentratsii streptomitsina v tkaniakh zdorovogo i porazhennogo tuberkulezom glaza v éksperimente.